Longboard Pharmaceuticals, Inc.
LBPH
Revenue
0.00
0.000.00%
-Assets
312.91M
▼-14.76M▼-4.50%
3 Months ChangeLiabilities
18.31M
▲4.35M▲31.15%
3 Months ChangeFree Cash Flow
-38.06M
▼-13.34M▼-53.97%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001193125-24-237160
2024-08-01
Form 10-Q
ID: 0000950170-24-089319
2024-08-01
Form 8-K
ID: 0000950170-24-089285
2024-07-01
Form 8-K
ID: 0000950170-24-079294
2024-06-10
Form 8-K
ID: 0000950170-24-071093
2024-05-24
Form 8-K
ID: 0000950170-24-064559
2024-05-02
Form 10-Q
ID: 0000950170-24-052137
2024-05-02
Form 8-K
ID: 0000950170-24-052111
2024-04-15
Form 8-K
ID: 0000950170-24-044244
2024-03-26
Form 8-K
ID: 0000950170-24-036596